Masayoshi Kubo
- Pharmacology top 0.5%
- Complementary and alternative medicine top 0.5%
- Molecular Biology
- Plant Science top 10%
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Hiroyuki IchikiMinoru OkadaYasuhiro KomatsuIwao SakakibaraToshihiro MiuraKeiichiro TanigawaJunzo KameiHiroshi Sasaki
- Topics
- Mangiferin and Mango Extracts (7 papers)Natural Antidiabetic Agents Studies (6 papers)Natural product bioactivities and synthesis (4 papers)
- Partner nations
- JapanChinaUnited States
In The Last Decade
Masayoshi Kubo
43 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 120
- Pharmacology 526
- Complementary and alternative medicine 504
- Molecular Biology 441
- Plant Science 343
- Endocrinology, Diabetes and Metabolism 262
Countries citing papers authored by Masayoshi Kubo
This map shows the geographic impact of Masayoshi Kubo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masayoshi Kubo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masayoshi Kubo more than expected).
Fields of papers citing papers by Masayoshi Kubo
This network shows the impact of papers produced by Masayoshi Kubo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masayoshi Kubo. The network helps show where Masayoshi Kubo may publish in the future.
Co-authorship network of co-authors of Masayoshi Kubo
This figure shows the co-authorship network connecting the top 25 collaborators of Masayoshi Kubo. A scholar is included among the top collaborators of Masayoshi Kubo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masayoshi Kubo. Masayoshi Kubo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | Preventive effects of baker's yeast-derived β-glucan on hypercholesterolemia in rats | 1 |
| 3 | 1 | |
| 4 | 58 | |
| 5 | 106 | |
| 6 | 126 | |
| 7 | 26 | |
| 8 | Hypolipidemic activity of Mangiferin in cholesterol-fed mice | 3 |
| 9 | 174 | |
| 10 | 52 | |
| 11 | 23 | |
| 12 | 0 | |
| 13 | 33 | |
| 14 | 144 | |
| 15 | 1 | |
| 16 | 1 | |
| 17 | 16 | |
| 18 | 9 | |
| 19 | 1 | |
| 20 | 13 |
About Masayoshi Kubo
Masayoshi Kubo is a scholar working on Pharmacology, Complementary and alternative medicine and Pharmacology, having authored 46 papers that have together received 1.7k indexed citations. Recurring topics across this work include Mangiferin and Mango Extracts (7 papers), Natural Antidiabetic Agents Studies (6 papers) and Natural product bioactivities and synthesis (4 papers). The work is most often cited by research in Complementary and alternative medicine (504 citations), Pharmacology (526 citations) and Biochemistry (113 citations). Masayoshi Kubo has collaborated with scholars based in Japan, China and United States. Frequent co-authors include Hiroyuki Ichiki, Minoru Okada, Yasuhiro Komatsu, Iwao Sakakibara, Toshihiro Miura, Keiichiro Tanigawa, Junzo Kamei, Hiroshi Sasaki, Eriko Ishihara and Naoki Iwamoto. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nutrients and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.